Intra-cellular Therapies Intrinsic Value – Intra-Cellular Therapies stock skyrockets to record high of $90.37 in impressive show of market confidence
☀️Trending News INTRA-CELLULAR ($NASDAQ:ITCI): Intra-Cellular Therapies is a biopharmaceutical company that specializes in developing innovative treatments for central nervous system [...]
Intra-Cellular Therapies’ RS Rating Soars to 83, Solidifying Market Leadership Status
🌥️Trending News INTRA-CELLULAR ($NASDAQ:ITCI): Intra-Cellular Therapies is a biopharmaceutical company that focuses on developing treatments for neuropsychiatric and neurodegenerative disorders. [...]
Assenagon Asset Management S.A. Boosts Stake in Intra-Cellular Therapies,
☀️Trending News INTRA-CELLULAR ($NASDAQ:ITCI): Intra-Cellular Therapies, Inc. is a biopharmaceutical company that focuses on developing novel treatments for neuropsychiatric and [...]
Intra-cellular Therapies Intrinsic Value Calculator – EVP of Intra-Cellular Therapies Sells 21262 Shares of Stock in Insider Transaction
☀️Trending News INTRA-CELLULAR ($NASDAQ:ITCI): The recent insider transaction conducted by the Executive Vice President of Intra-Cellular Therapies, Inc. has created [...]
Intra-cellular Therapies Stock Fair Value – Intra-Cellular Therapies to Present at Canaccord Genuity’s 43rd Annual Growth Conference
☀️Trending News INTRA-CELLULAR ($NASDAQ:ITCI): Intra-Cellular Therapies, Inc. is a biopharmaceutical company that is focused on developing and commercializing treatments for [...]
Intra-cellular Therapies Stock Intrinsic Value – INTRA-CELLULAR THERAPIES Reports Second Quarter FY2023 Earnings Results on August 3 2023
🌥️Earnings Overview On August 3 2023, INTRA-CELLULAR THERAPIES ($NASDAQ:ITCI) disclosed their financial results for the second quarter of FY2023, which [...]
Jennison Associates LLC Sells Shares of Intra-Cellular Therapies, at Defense World
☀️Trending News INTRA-CELLULAR ($NASDAQ:ITCI): Jennison Associates LLC recently sold shares of Intra-Cellular Therapies, Inc. to Defense World. Intra-Cellular Therapies is [...]
Intra-cellular Therapies Stock Fair Value Calculation – Avidity Partners Management LP Reduces Holdings in Intra-Cellular Therapies,
🌥️Trending News INTRA-CELLULAR ($NASDAQ:ITCI): Avidity Partners Management LP has recently decreased their stake in Intra-Cellular Therapies, Inc. at Defense World. [...]
Intra-Cellular Therapies’ Depression Data Receives Investment Rating Upgrade
Trending News 🌧️ INTRA-CELLULAR ($NASDAQ:ITCI): Investment prospects of Intra-Cellular Therapies (ICT) have recently been strengthened by positive data on its [...]
Intra-Cellular Therapies Beats Expectations with $95.31M Revenue, GAAP EPS of -$0.46
Trending News 🌥️ INTRA-CELLULAR ($NASDAQ:ITCI): Intra-Cellular Therapies, Inc., is a biopharmaceutical company focused on developing innovative and potentially transformative treatments [...]
